PITTSBURGH, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (POAI), a leader in AI-driven drug discovery, today announced that it has entered into a binding letter of intent with Renovaro, ...
With the global biomarker discovery market valued at $14.5 billion in 2024 and projected to grow at a 19.4% CAGR through 2030, Predictive Oncology (POAI) is poised to lead in precision oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results